These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22069486)

  • 41. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
    Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
    Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CXCR4
    Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
    Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML.
    Agarwal A; Fleischman AG; Petersen CL; MacKenzie R; Luty S; Loriaux M; Druker BJ; Woltjer RL; Deininger MW
    Blood; 2012 Sep; 120(13):2658-68. PubMed ID: 22889761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
    Boyerinas B; Zafrir M; Yesilkanal AE; Price TT; Hyjek EM; Sipkins DA
    Blood; 2013 Jun; 121(24):4821-31. PubMed ID: 23589674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The SDF-1α/CXCR4 axis is required for proliferation and maturation of human fetal pancreatic endocrine progenitor cells.
    Kayali AG; Lopez AD; Hao E; Hinton A; Hayek A; King CC
    PLoS One; 2012; 7(6):e38721. PubMed ID: 22761699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL.
    Sison EA; Magoon D; Li L; Annesley CE; Romagnoli B; Douglas GJ; Tuffin G; Zimmermann J; Brown P
    Oncotarget; 2015 Oct; 6(31):30902-18. PubMed ID: 26360610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
    Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
    PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
    van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML
    Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
    Liepelt A; Tacke F
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.
    Colmone A; Amorim M; Pontier AL; Wang S; Jablonski E; Sipkins DA
    Science; 2008 Dec; 322(5909):1861-5. PubMed ID: 19095944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome.
    Yang R; Pu J; Guo J; Xu F; Zhang Z; Zhao Y; Zhang X; Gu S; Chang C; Li X
    Med Oncol; 2012 Jun; 29(2):1202-8. PubMed ID: 21556934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenosine A2A receptor activation reduces brain metastasis via SDF-1/CXCR4 axis and protecting blood-brain barrier.
    Chen L; Li L; Zhou C; Chen X; Cao Y
    Mol Carcinog; 2020 Apr; 59(4):390-398. PubMed ID: 32037613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception.
    Dimova I; Karthik S; Makanya A; Hlushchuk R; Semela D; Volarevic V; Djonov V
    J Cell Mol Med; 2019 Jun; 23(6):3916-3926. PubMed ID: 30950188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis.
    Gomes AL; Carvalho T; Serpa J; Torre C; Dias S
    Blood; 2010 May; 115(19):3886-94. PubMed ID: 20009035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
    Zhu WB; Zhao ZF; Zhou X
    J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.
    Barbieri F; Bajetto A; Thellung S; Würth R; Florio T
    Expert Opin Drug Discov; 2016 Nov; 11(11):1093-1109. PubMed ID: 27598329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.
    Migliaccio AR; Martelli F; Verrucci M; Migliaccio G; Vannucchi AM; Ni H; Xu M; Jiang Y; Nakamoto B; Papayannopoulou T; Hoffman R
    Exp Hematol; 2008 Feb; 36(2):158-71. PubMed ID: 18206727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
    Tavor S; Petit I; Porozov S; Avigdor A; Dar A; Leider-Trejo L; Shemtov N; Deutsch V; Naparstek E; Nagler A; Lapidot T
    Cancer Res; 2004 Apr; 64(8):2817-24. PubMed ID: 15087398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.